Cancer News and Research

Latest Cancer News and Research

Scientists find better treatment options for patients with advanced colorectal cancer

City of Hope, a world-renowned cancer research and treatment organization, today announced study results of a Phase 2 clinical trial showing monotherapy with sotorasib resulted in anti-tumor activity and a favorable benefit-risk profile among heavily pretreated patients with advanced colorectal cancer. The research was published today in Lancet Oncology.

16 Dec 2021

National Preventive Health Strategy 2021-2030 focuses on primary health care and physical activity

With Australians living almost 11 years in poor health on average, equating to around 13 per cent of their life, the Australian Physiotherapy Association (APA) welcomes the National Preventive Health Strategy 2021-2030 to urgently address health inequalities, and embed ‘prevention’ in our health system.

16 Dec 2021

New combined therapy shows promising results in treating triple negative breast cancer

A drug used to treat cardiac failure has shown promising results in treating triple negative breast cancer, according to Houston Methodist researchers who released results this week on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients.

15 Dec 2021

Novel imaging method used to map glycosylation patterns linked with Alzheimer’s disease

Using new methodology, University of Kentucky researchers have mapped the variations in sugar chains attached to brain proteins from deceased healthy individuals or individuals with Alzheimer's disease.

15 Dec 2021

SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment

Researchers demonstrate that the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 require endogenous IFITM2 expression for efficient replication.

15 Dec 2021

Combination treatment can effectively inhibit tumor growth

Researchers at the Paul Scherrer Institute PSI have tested various methods to check how effective they are in combatting certain types of cancer.

15 Dec 2021

Scientists develop novel method to monitor remote immune processes within cells

Our immune systems work hard to keep us healthy and to protect us against bacteria, viruses, fungi, parasites and cancerous cells.

15 Dec 2021

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.

15 Dec 2021

BrainGlobe; An Open-Source Platform for Neuroscientists

An interview with Professor Troy Margrie, Associate Director of the Sainsbury Wellcome Centre, and Dr. Adam Tyson, Scientific Software Lead at the Institute of Cancer Research.

15 Dec 2021

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Depixus®, a biotechnology company, today announces it has raised EUR 30.6 million in an oversubscribed Series A financing.

From Depixus® 15 Dec 2021

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

An international research team co-led by scientists at Roswell Park Comprehensive Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified an important accelerator of treatment-resistant prostate cancer.

14 Dec 2021

Medical AI and radiologist experts may be vulnerable to adversarial attacks

Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks.

14 Dec 2021

Driving up immunity at tumor site may help enhance immunotherapy treatments

Driving up the immune response at the site of a cancer tumor with nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease, new research in mice suggests.

14 Dec 2021

Study reveals molecular players involved in the onset of leukemia

A new study led by João T. Barata from Instituto de Medicina Molecular João Lobo Antunes (iMM, Portugal), and J. Andrés Yunes from Centro Infantil Boldrini (Brazil), published now in the scientific journal Nature Communications, shows that changes in a protein called IL-7R are sufficient to initiate a type of leukemia.

14 Dec 2021

Salk study could help find better treatment options for colorectal cancer patients

Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues.

14 Dec 2021

Study assesses health care providers' preferences, practices related to colorectal cancer screening

Colorectal cancer is the second-most frequent cause of cancer-related deaths in the U.S. Despite the availability of several effective screening tests, colorectal cancer screening rates remain below national goals.

14 Dec 2021

"Supermere" discovery may offer clues to earlier diagnoses and treatment of several diseases

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a "supermere," which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer's disease and even COVID-19.

14 Dec 2021

Cells with oncogenic mutations overtake human tissue with age, research shows

It's worth noting, in light of recently published research, that a majority of people won't be diagnosed with cancer in their lifetimes. According to the National Cancer Institute, about 40% of people will, which means 60% won't.

14 Dec 2021

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

A drug combination can safely prevent transplanted stem cells, known as a graft, from attacking the recipient's body, allowing them to develop into healthy new blood and immune cells, a new study shows.

14 Dec 2021

Researchers uncover a key role for SIRT1 enzyme in T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of leukemia. Despite advances in treatments, patients have an extremely poor prognosis, highlighting the need to explore the genetic components that lead to the formation of T-ALL, as well as the need to discover new targeted therapeutic approaches and treatment resistance.

14 Dec 2021

Cancer News and Research

Latest Cancer News and Research

Scientists find better treatment options for patients with advanced colorectal cancer

National Preventive Health Strategy 2021-2030 focuses on primary health care and physical activity

New combined therapy shows promising results in treating triple negative breast cancer

Novel imaging method used to map glycosylation patterns linked with Alzheimer’s disease

SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment

Combination treatment can effectively inhibit tumor growth

Scientists develop novel method to monitor remote immune processes within cells

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

BrainGlobe; An Open-Source Platform for Neuroscientists

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

Medical AI and radiologist experts may be vulnerable to adversarial attacks

Driving up immunity at tumor site may help enhance immunotherapy treatments

Study reveals molecular players involved in the onset of leukemia

Salk study could help find better treatment options for colorectal cancer patients

Study assesses health care providers' preferences, practices related to colorectal cancer screening

"Supermere" discovery may offer clues to earlier diagnoses and treatment of several diseases

Cells with oncogenic mutations overtake human tissue with age, research shows

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

Researchers uncover a key role for SIRT1 enzyme in T-cell acute lymphoblastic leukemia

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in